Dr. Judy Chou is the President and CEO of AltruBio, leading the development of therapies for autoimmune diseases. With over 25 years in biotech, she has held senior roles at Bayer, Pfizer, and Genentech. Dr. Chou earned her Ph. D. from Yale University and was a research faculty member at Harvard Medical School.
Dr. Chou is passionate about advancing science and bringing innovative treatments to patients. She enjoys mentoring and is a recognized leader, named one of the Most Influential Women in Business by the San Francisco Business Times and a top woman in biopharma by Endpoints News.
Her first project in the industry was as a BLA co-author for Humira, now one of the worlds best-selling drugs.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.